Position in ACAD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,664,965
-$69,769,536 QoQ
Shares Held
184,386
-94.5% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. ACAD ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,664,965 | 184,386 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $74,434,501 | 3,343,868 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $60,632,608 | 2,270,034 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,466,863 | 1,943,152 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $52,509,490 | 2,434,376 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $39,340,153 | 2,368,462 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $49,547,293 | 2,700,125 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $32,695,942 | 2,125,874 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $33,610,200 | 2,068,320 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $30,486,275 | 1,648,798 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,647,482 | 1,777,307 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $33,943,796 | 1,628,781 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $59,981,457 | 2,504,445 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $51,086,607 | 2,714,485 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,887,187 | 2,882,361 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $47,768,909 | 2,919,860 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $30,592,799 | 2,171,242 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $56,484,769 | 2,332,154 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $78,256,289 | 3,352,883 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $43,226,910 | 2,602,463 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $71,331,896 | 2,924,637 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $40,689,721 | 1,577,121 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $86,742,912 | 1,622,576 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $70,831,653 | 1,717,131 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $68,839,420 | 1,420,248 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $60,685,745 | 1,436,349 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||